DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

H.C. Wainwright Maintains Buy on ChemoCentryx, Raises Price Target to $60

H.C. Wainwright maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and raises the price target from $40 to $60.

Benzinga · 01/24/2020 12:39

H.C. Wainwright maintains ChemoCentryx (NASDAQ:CCXI) with a Buy and raises the price target from $40 to $60.